Isozaki, H., Abbasi, A., Nikpour, N., Langenbucher, A., Su, W., Stanzione, M., Frisco-Cabanos, H., Siddiqui, F., Phan, N., Jalili, P., Oh, S., Timonina, D., Bilton, S., Gomez-Caraballo, M., Archibald, H., Nangia, V., Dionne, K., Riley, A., Lawlor, M., Banwait, M., Cobb, R., Zou, L., Dyson, N., Ott, C., Benes, C., Getz, G., Chan, C., Shaw, A., Lin, K., Sequist, L., Piotrowska, Z., Engelman, J., Lee, J-L., Maruvka, Y., Buisson R., Lawrence, M. & Hata, A. APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer. BioRxiv

#Oh, S., #Bournique, E., Bowen, D., Jalili, P., Sanchez, A., Ward, I., Dananberg, A., Manjunath, L., Tran, G., Semler, B., Maciejowski, J., Seldin, M., and Buisson, R. Genotoxic stress and Viral Infection Induce Transient Expression of APOBEC3A and Pro-Inflammatory Genes Through Two Distinct Pathways. Nature Communications (in Press). #co-first author

Zhao, K., Zhang, Q., Flanagan, S., Lang, X., Jiang, L., Parsels, LA., Parsels, JD., ZouW., Lawrence, TS., Buisson, R., Green, MD., Morgan, MA. Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-dependent Manner. (2021) Molecular Cancer Research

#Langenbucher, A., #Bowen, D., #Sakhtemani, R., Bournique, E., Wise, J., *Zou, L., *Bhagwat, A., *Buisson, R., and *Lawrence, M. An extended APOBEC3A mutation signature in cancer. (2021) Nature Communications. PMID: 33707442 #co-first author *corresponding author


Jalili, P., Bowen, D., Langenbucher, A., Park, P., Aguirre, K., Corcoran, R., Fleischman A., Lawrence, M., Zou, L., and Buisson, R. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots. (2020) Nature Communications. Jun 12;11(1):2971.


Buisson, R., Langenbucher, A., Bowen, D., Kwan, EE., Benes, CH., Zou, L., and Lawrence, MS. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features. (2019) Science. Jun 28;364(6447).

Dubois, E., Guitton-Sert, L., Béliveau, M., Parmar, K., Chagraoui, J., Vignard, J., Pauty, J., Caron, M., Coulombe, Y., Buisson, R., Jacquet, K., Gamblin, C., Gao, Y., Laprise, P., Lebel, M., Sauvageau, G., D’Andrea, A., and Masson, J-Y. A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2. (2019) Nucleic Acids Research. Aug 22;47(14):7532-7547.

Moquin, DM., Genois, MM.,  Zhang, JM., Ouyang, J., Yadav, T., Buisson, R., Yazinski, SA.,  Tan, J., Boukhali, M., Gagne, JP.,  Poirier, GG., Lan, L., Haas, W., and Zou, L.  Localized protein biotinylation at DNA damage sites identifies ZPET, a repressor of homologous recombination. (2019) Genes & Development. Jan 1;33(1-2):75-89.


Cheng, X., Jobin-Robitaille, O., Billon, P., Buisson, R., Niu, H., Lacoste, N., Abshiru, N., Côté, V., Thibault, P., Kron, SJ., Sung, P., Brandl, CJ., Masson, JY., and Côté, J. Phospho-dependent recruitment of the yeast NuA4 acetyltransferase complex by MRX at DNA breaks regulates RPA dynamics during resection. (2018) Proceedings of the National Academy of Sciences. Oct 2;115(40):10028-10033

Bélanger, F., Fortier, E., Dubé, M., Lemay, JF., Buisson, R., Masson, JM., Elsherbiny, A., Costantino, S., Carmona, E., Mes-Masson, AM., Wurtele, H., and Drobetsky, E. Replication Protein A Availability During DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells. (2018) Cancer Research. Oct 1;78(19):5561-5573.

Kabeche, L., Nguyen, H.D., Buisson, R., and Zou, L. A Mitosis-specific and R-loop driven ATR pathway promotes faithful chromosome segregation. (2018) Science. Jan 5;359(6371):108-114. (Commented in Science 2018 Jan 5;359(6371):30-31 and Cancer Discovery 2018 Jan;8(1):11).


Boulay, B., Sandoval, GJ., Riggi, N., Iyer, S., Buisson, R., Naigles, B., Awad, ME., Rengarajan, S., Volorio, A., McBride, MJ., Broye, LB., Zou, L., Stamenkovic, I., Kadoch, C and Rivera, MN. Cancer-specific retargeting of BAF complexes by a prion-like domain. (2017) Cell. Sep 21;171(1):163-178.

Buisson, R., Lawrence, MS., Benes, CH., and Zou, L. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition. (2017) Cancer Research Sep 1;77(17):4567-4578.

Yazinski, SA., Comaills, V., Buisson, R., Ho, CH., Todorova, T., Nguyen, HD., Orsulic, S., Ellisen, LW., Benes, CH., Maheswaran, S., Haber, DA., and Zou, L. ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells. (2017) Genes & Development. Feb 1;31(3):318-332.

Buisson, R., Joshi, N., Ho, CK., Rodrigue, A., Foo, TK., Hardy, E., Haas, W., Xia, B., Masson, J-Y., and Zou, L. Coupling of Homologous Recombination and the Checkpoint by ATR. (2017) Molecular Cell. 19;65(2):336-346.


Comaills, V,. Kabeche, L,. Morris, R,. Buisson, R,. Yu, M,. Madden, MW,. LiCausi, JA,. Boukhali, M,. Tajima, K,. Pan, S,. Aceto, N,. Sil, S,. Zheng, Y,. Sundaresan, T,. Yae, T,. Jordan, NV,. Miyamoto, DT,. Ting, DT,. Ramaswamy, S,. Haas, W,. Zou, L,. Haber, DA,. Maheswaran, S. Genomic Instability Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition. (2016) Cell Reports. Dec 6;17(10):2632-2647

Gaullier, G., Miron, S., Pisano, S., Buisson, R., Le Bihan, YV., Tellier-Lebegue, C., Messaoud, W., Roblin, P., Guimaraes, B., Thai, R., Giraud-Panis, M-J., Gilson, E., and Le Du, M-H. A higher-order entity formed by the flexible assembly of TRF2 and RAP1. (2016) Nucleic Acids Research. Feb 29;44(4):1962-76


Buisson, R., Boisvert, JL., Benes, CH., and Zou, L. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase. (2015) Molecular Cell. Sep 17;59(6):1011-24.


Pauty, P., Rodrigue, A., Couturier, A., Buisson, R., and Masson, JY., Exploring the roles of PALB2 at the crossroads of DNA repair and cancer. (2014) Biochemical Journal. Aug 1;461(3):539.

Buisson, R,. Niraj, J,. Pauty, J,. Maity R, Zhao,. W, Coulombe,. Y, Sung,. P,. and Masson, JY. Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks. (2014) Cell Reports. Feb 13;6(3):553-64.


Buisson, R., and Masson, J-Y. Functions of PALB2 and BRCA2 tumor suppressors in DNA double-strand break repair. (2013) Medecine/Science. 2013 Mar;29(3):301-7.

Maity, R., Pauty, J., Krietsch, J., Buisson, R., Genois, MM., and Masson, JY. GST-His purification: A Two-step Affinity Purification Protocol Yielding Full-length Purified Proteins. (2013) Journal of Visualized Experiments. Oct 29;(80).


Buisson, R., and Masson J-Y. PALB2 self-interaction controls homologous recombination. (2012) Nucleic Acids Research. 40(20):10312-23.

Genois, G., Mukherjee, A., Ubeda, JM., Buisson, R., Paquet, E., Roy, G., Plourde, G., Coulombe, Y., Ouellette, M., and Masson, JY. Interactions between BRCA2 and RAD51 for promoting homologous recombination in Leishmania infantum(2012) Nucleic Acids Research. 40(14):6570-84

Bleuyard, JY., Buisson, R., Masson, JY., and Esashi, F. ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair. (2012) EMBO reports. 13(2):135-41


Buisson, R., Dion-Côté, AM., Launay, H., Coulombe, Y., Cai, H., Stasiak, AZ., Stasiak, A., Xia, B., and Masson, JY. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination. (2010) Nature Structural & Molecular Biology. 17(10):1247-54.


*Poulet, A., *Buisson, R., Faivre-Moskalenko,C., Koelblen, M., Amiard, S., Montel, F., Cuesta-Lopez, S., Bornet, O., Guerlesquin, F., Godet, T., Moukhtar, J., Argoul, F., Déclais, AC., Lilley, DM., Ip, SC, West, SC., Gilson, E. and Giraud-Panis, MJ. TRF2 promotes and remodels telomeric Holliday Junctions. (2009) EMBO Journal. 18;28(6):641-51. (*co-first authors)